Lymphohaematopoietic Growth Factors in Cancer Therapy

Roland Mertelsmann (Herausgeber)

VII, 90 Seiten
1990
Springer Berlin (Hersteller)
978-3-540-53086-2 (ISBN)

Lese- und Medienproben

38,65 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
Part of a series sponsored by the European School of Oncology, this book reports on recent experimental and clinical progress in the evaluation of cytokines in treatment concepts for cancer patients.
Recent experimental and clinical progress in the evaluation of cytokines in treatment concepts for cancer patients is the central theme of this book in the "ESO Monographs" series. The discussion revolves around the experimental basis as well as current clinical experience with the use of human recombinant cytokines. It gives the state of the art and, as such, puts into perspective potential areas of growth and future research.

Interleukins and haematopoietic growth factors; mechanisms of T-cell activation; characteristics of LAK cells and their use in adoptive therapy of cancer in experimental animals; interleukin 2 - in vivo induction of effector cells; cellular immunotherapy of cancer - the use of lymphokine-activated natural killer (LANAK) cells; interleukin 2 - clinical aspects; interleukin 2 and LAK cells.

Zusatzinfo 8 figs., 14 tabs.
Verlagsort Berlin
Sprache englisch
Gewicht 540 g
Einbandart gebunden
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium Querschnittsbereiche Infektiologie / Immunologie
ISBN-10 3-540-53086-X / 354053086X
ISBN-13 978-3-540-53086-2 / 9783540530862
Zustand Neuware
Haben Sie eine Frage zum Produkt?